These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2743333

  • 1. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA, Buettner GR, Oberley LW, Burns CP.
    Cancer Res; 1998 Jul 01; 58(13):2809-16. PubMed ID: 9661895
    [Abstract] [Full Text] [Related]

  • 3. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
    Wagner BA, Buettner GR, Burns CP.
    Cancer Res; 1992 Nov 01; 52(21):6045-51. PubMed ID: 1394229
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 5. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X, Lu X, Arthur G.
    Anticancer Res; 1992 May 15; 12(5):1659-62. PubMed ID: 1444233
    [Abstract] [Full Text] [Related]

  • 6. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR, Hoffman LH, Snyder F.
    Cancer Res; 1986 Nov 01; 46(11):5803-9. PubMed ID: 3756924
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.
    J Natl Cancer Inst; 1987 Feb 01; 78(2):219-22. PubMed ID: 3468284
    [Abstract] [Full Text] [Related]

  • 11. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
    Petersen ES, Kelley EE, Modest EJ, Burns CP.
    Cancer Res; 1992 Nov 15; 52(22):6263-9. PubMed ID: 1423272
    [Abstract] [Full Text] [Related]

  • 12. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M, Fukuhara T, Winton EF, Berdel WE, Vogler WR.
    Exp Hematol; 1994 Jan 15; 22(1):13-8. PubMed ID: 8282054
    [Abstract] [Full Text] [Related]

  • 13. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F, Daniel LW.
    Cancer Chemother Pharmacol; 1998 Jan 15; 42(4):319-26. PubMed ID: 9744778
    [Abstract] [Full Text] [Related]

  • 14. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Ahmad I, Filep JJ, Franklin JC, Janoff AS, Masters GR, Pattassery J, Peters A, Schupsky JJ, Zha Y, Mayhew E.
    Cancer Res; 1997 May 15; 57(10):1915-21. PubMed ID: 9157985
    [Abstract] [Full Text] [Related]

  • 15. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Small GW, Strum JC, Daniel LW.
    Lipids; 1997 Jul 15; 32(7):715-23. PubMed ID: 9252959
    [Abstract] [Full Text] [Related]

  • 16. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
    Lu X, Arthur G.
    Cancer Res; 1992 May 15; 52(10):2813-7. PubMed ID: 1581895
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
    Magistrelli A, Villa P, Benfenati E, Modest EJ, Salmona M, Tacconi MT.
    Drug Metab Dispos; 1995 Jan 15; 23(1):113-8. PubMed ID: 7720513
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
    Wilcox RW, Wykle RL, Schmitt JD, Daniel LW.
    Lipids; 1987 Nov 15; 22(11):800-7. PubMed ID: 3444369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.